Vesalius to present twice at EuroPCR 2024
Dr Peter Skarsgard, Vesalius President and Chief Medical Officer, will be presenting Vesalius TMVr solution twice during the EuroPCR 2024 event held in Paris from May 13th to 17th, 2024. ...
on the comprehensive treatment of degenerative mitral valve disease, a leading cause of mitral regurgitation, by utilizing advanced non-surgical techniques.
is the percutaneous treatment of degenerative mitral regurgitation with a novel medical device that respects and expalnds upon the proven principles of mitral valve surgery.
To provide a safe and non-invasive treatment for all DMR patients by creating an innovative and reliable medical device that save lives
Dr Peter Skarsgard, Vesalius President and Chief Medical Officer, will be presenting Vesalius TMVr solution twice during the EuroPCR 2024 event held in Paris from May 13th to 17th, 2024. ...
Vesalius Selected as a Top Innovation at PCR London Valves 2023.
Vesalius selected to present at PCR London Valves 2023